The Centers for Disease Control and Prevention has awarded a groundbreaking $1.4 million grant to University of Albany professor Melonie Walcott. This crucial research aims to transform HIV prevention strategies for Black women in New York State.
Innovative PrEP-WISE Program Targets Healthcare Disparities
The four-year project, dubbed “PrEP-WISE,” will explore how Black women interact with HIV prevention medication PrEP. Professor Walcott’s research responds to alarming statistics showing Black Americans represent 37% of new HIV infections.
“Black women face unique vulnerabilities to HIV, including systemic inequities and socioeconomic challenges,” explains Walcott. “This study seeks to address those gaps through culturally relevant interventions.”
Community-Centered Research Approach Breaks New Ground
Walcott’s team will conduct in-depth interviews with 25 women and 10 healthcare providers to understand PrEP access barriers. The research actively involves faith-based organizations and community partners to ensure authentic engagement.
The study extends beyond traditional medical settings into community spaces like salons, churches, and corner stores. This grassroots approach aims to share life-saving information where women naturally gather.
Comprehensive Education Sessions Address Multiple Health Factors
The project’s second phase will launch peer-led intervention sessions focusing on systemic inequalities and sustainable well-being. These sessions will cover HIV vulnerability assessment, gender dynamics, and PrEP education.
Financial literacy tools will also be integrated into the program. This holistic approach recognizes the connection between economic stability and health outcomes for Black women.
